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The Panton-Valentine leukocidin is associated with
staphylococcal skin and pulmonary infections. We describe
a school outbreak of skin infections and the public health
response to it. Nasal carriage of a Panton-Valentine leuko-
cidin–positive Staphylococcus aureus clone was detected
only in previously ill classmates and their family members. 
Staphylococcus aureus colonizes approximately 30% ofthe general population and up to 50% of persons who
are intravenous drug users, diabetics, or healthcare work-
ers. The organism is mainly transmitted between persons
by close contact (1,2). In addition to its increasing ability
to resist antimicrobial agents, S. aureus displays a wide
array of virulence factors that render it capable of causing
a larger spectrum of infections than any other bacteria (1). 
Exotoxins constitute essential components of the viru-
lence mechanisms of S. aureus. Nearly all strains secrete
hemolysins, nucleases, proteases, lipases, hyaluronidase,
and collagenase, which convert host tissues into nutrients
required for bacterial growth (3). Some strains produce
additional exoproteins that may be responsible for particu-
lar clinical manifestations, including the staphylococcal
enterotoxins, the toxic-shock syndrome toxin-1, the exfo-
liative toxins, and the Panton-Valentine leukocidin (PVL)
(3). PVL, a bicomponent cytotoxin encoded by two con-
tiguous and cotranscribed genes carried on a bacterio-
phage, causes leukocyte destruction and tissue necrosis.
This cytotoxin is produced by <5% of S. aureus isolates
and has been associated with necrotic lesions involving the
skin and with severe necrotizing pneumonia (4,5). 
The Study
From September 1999 to November 2000, 6 of the 22
students from a single third-grade classroom in a town of
12,000 in western Switzerland had 13 episodes of skin
infections, including furuncles, abscesses, and cellulitis.
The outbreak peaked in October and November 2000, with
three new cases and four relapses (Figure 1). Two children
were hospitalized. Most patients were treated with sys-
temic antimicrobial agents. Some needed surgical inci-
sions and drainage. Six cultures were performed and con-
sistently grew S. aureus resistant to penicillin and amoxi-
cillin (PRSA) and susceptible to flucloxacillin, amoxi-
cillin/clavulanic acid, cephalosporins, erythromycin,
doxycycline, clindamycin, trimethroprim/sulfamethoxa-
zole, ciprofloxacin, and rifampin.
At the end of November 2000, after health authorities
were notified, nasal screening for carriage of S. aureus was
performed first in the 22 classmates and their 2 teachers
and next in the families of those who had had skin infec-
tions or who had been found to be carriers of PRSA. Nasal
cultures were collected by using rayon swabs moistened
with 5% NaCl, rotated five times in both anterior nares.
The samples were carried within 2 hours to the laboratory
and kept overnight at 35°C in an enrichment Mueller-
Hinton broth with 5% NaCl. They were then plated onto
mannitol-salt agar and sheep blood agar. The plates were
incubated at 35°C with 5% CO2 for 24 hours. Persons with
mannitol-fermenting, coagulase-positive colonies were
considered carriers of S. aureus after species were con-
firmed and antimicrobial susceptibility was determined in
an automated system (Vitek 2, bioMérieux, France). PRSA
were saved and subsequently typed by pulsed-field gel
electrophoresis (PFGE) after digestion by SmaI. Three iso-
lates representative of the three clones were forwarded to
the French Reference Center for Staphylococcal Toxemia,
where polymerase chain reaction (PCR)-based methods
were used to detect genetic sequences encoding enterotox-
ins, exfoliative toxins, toxic-shock syndrome toxin-1, β-
hemolysin, LukE-LukD leukotoxin, and PVL (4). 
Ten of the 22 classmates and 1 of the 2 teachers (46%)
were colonized with S. aureus. None harbored methicillin-
resistant S. aureus (MRSA). Nine carried PRSA, including
four of the six previously infected children (the other two
had negative cultures). Two carried penicillin-susceptible
isolates. The nine PRSA carriers and the two previously
infected students with no nasal S. aureus had 36 family
members, 3 of whom had recently also had skin infections.
These three persons belonged to two families that includ-
ed formerly infected classmates. Thirty-five family mem-
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bers were screened. Cultures grew S. aureus in 15 (43%),
of whom 12 harbored PRSA and 3, penicillin-susceptible
isolates. The results of PFGE, including PRSA isolates still
found after the first set of preventive measures had been
taken (see next paragraph), are shown in Figure 2. Genes
encoding for PVL were found only in clone A (Table),
which was harbored by three of the six previously infected
classmates and six of their family members. The three
clones showed the same susceptibility profile, which also
corresponded to the profile found previously in the infect-
ing isolates.
While waiting for PFGE and PCR results, we imple-
mented measures derived from those in use for MRSA in
hospitals (6). After information and teaching had been pro-
vided to the students and their parents, nasal mupirocin
twice a day and chlorhexidine showers once a day for 5
days were prescribed for all the members of the nine fam-
ilies that included >1 PRSA carrier, regardless of clonal
type. These measures were repeated a second time in five
families because >1 of their members still harbored PRSA
1–2 weeks after the first set of measures was implemented.
Moreover, alcohol-based hand rubs (500-mL multiuse con-
tainers) were used several times a day for 3 to 4 weeks in
the nine families and by every student and teacher when
entering and leaving the classroom.
One year later, no new case of skin infection had been
detected among this population through active surveillance
by the school nurse or periodic enquiries to the local pedi-
atricians. Two children had relapsed 6 months later, in June
2001 (no culture available). Nasal mupirocin and
chlorhexidine showers were repeated for 5 days in their
families.
Conclusions
PVL has been associated with staphylococcal skin and
pulmonary infections by means of retrospective and
prospective studies comparing the clinical features of
patients infected with PVL gene-positive or negative
staphylococci (4,5). The intrafamilial spread of such
strains (e.g., from mother to infant through breastfeeding)
has been reported (7–9). To our knowledge, this report is
the first on an outbreak attributable to a PVL-positive S.
aureus clone that spread among schoolchildren and their
families.
Lina et al. found that 50%-93% of S. aureus responsi-
ble for cutaneous abscess, cellulites, or furunculosis and
85% of those responsible for community-acquired pneu-
monia harbored the genes encoding for PVL compared
with none of those causing diseases such as nosocomial
pneumonia, infective endocarditis, urinary tract infection,
enterocolitis, or toxic-shock syndrome (4). Gillet et al.
found that 16 patients with community-acquired pneu-
mona attributable to PVL-positive S. aureus were younger
(median age 14.8 years), had less underlying disorders,
and had more often had influenza-like syndromes or furun-
cles than 36 patients with community-acquired pneumonia
due to S. aureus without PVL genes. The patients in the
first group also had a more severe disease course and 75%
of them died; in the other group, 47% died (5). Dufour et
al. reported on 14 cases of community-acquired infections
due to PVL-positive MRSA, suggesting the community
emergence of a new superadapted S. aureus strain (9). 
In our study, nine persons belonging to a population of
classmates, teachers, and their family members were found
to be nasal carriers of a single clone of PVL gene–positive,
methicillin-susceptible S. aureus after six students and
three of their relatives had had relapsing episodes of skin
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Figure 1. Cases of skin infections among schoolchildren,
Switzerland, September 1999–November 2001. I: Nasal mupirocin
twice a day, chlorhexidine showers once a day for carriers of peni-
cillin-resistant Staphylococcus aureus and their family members (5
days); alcoholic hand rubs in the classroom and at home (3–4
weeks). II: Repeated measures (5 days) in those still found to be
carriers and in their family members. III: Repeated measures lim-
ited to the two relapsing children and their family members.
Figure 2. Band patterns of the Staphylococcus aureus isolates cul-
tured from nasal swabs (pulsed-field gel electrophoresis). Some
persons had two consecutive positive cultures (see text).
infections in 13 months. Overall, the 44% prevalence of S.
aureus carriage in this population was higher than the
expected rate of 30% (2) but close to it without taking the
isolates belonging to the PVL-positive clone (A) into
account. Although the numbers were small and this differ-
ence could be due to chance, this finding suggests an addi-
tion to the usual rate of colonization caused by the intro-
duction of clone A into the studied population, an event that
seemed to have occurred recently, as suggested by its very
homogenous PFGE profile as compared with the others. 
Even though the S. aureus responsible for infections
had not been saved and could therefore not be tested, the
nasal recovery of a single PVL-positive clone only from
persons who had had skin infections or from their family
members strongly suggests pathogenicity of this particular
clone. Indeed, Prevost et al. found identical PFGE profiles
in nasal and furuncle PVL-positive isolates from patients
with skin infections (10). Although only one isolate repre-
sentative of each clone was tested for PVL genes, we
believe that, given the large size of the bacteriophage car-
rying these genes, it is very unlikely that isolates showing
the same PFGE pattern could differ regarding their PVL
status. In addition, the S. aureus found in subsequent nasal
swabs from the same persons in our study belonged con-
sistently to the same clone as the first cultured isolate, sug-
gesting that these persons were colonized with a single
clone each and that the hazard of picking one among sev-
eral strains of S. aureus for PFGE typing was low.
Similarly, Peacock et al. found that 29 of 31 patients with
>1 positive nasal culture for S. aureus within a 1-month
period harbored the same clone over time (11). The pres-
ence of LukD and LukE genes in addition to genes encod-
ing for PVL was considered trivial since these toxins do
not appear to be linked with specific infections (3).
To prevent new cases or more severe diseases, the deci-
sion was made to implement MRSA measures derived
from those in use in many hospitals (6). These measures
consisted of the repeated application of nasal mupirocin
and chlorhexidine showers for those considered at risk for
infection or transmission and the simultaneous use of alco-
hol-based hand rubs for the same persons, plus all of their
classmates and teachers. Given the absence of new cases
and the occurrence of only two relapses 1 year after these
measures were implemented, they may have played a role
in controlling this outbreak.
In summary, PVL-positive S. aureus may spread
between persons in close contact and cause disease, main-
ly among otherwise healthy children or young adults. The
clinical manifestations may initially correspond to skin
infections and then progress to severe necrotizing pneumo-
nia with a high death rate. Despite its limitations, this study
suggests that future research should investigate whether
the early identification of such strains, coupled with time-
ly measures aimed at decolonizing carriers and interrupt-
ing person-to-person transmission, could prevent or con-
trol potentially lethal outbreaks.
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